Gilead to buy biotech firm Ouro Medicines in over $2 billion deal


March 23 (Reuters) – ‌Gilead ‌Sciences said ​on Monday it ‌would ⁠buy privately ⁠held ​biotech ​firm ​Ouro ‌Medicines in a deal ‌worth ​up ​to $2.18 ​billion.

(Reporting ‌by Mariam ​Sunny ​in ​Bengaluru; ‌Editing by ​Shilpi ​Majumdar)



Source link

  • Related Posts

    Pizza Hut bought by private equity firm that owns 24 Hour Fitness

    It may seem like an unlikely combination: Pizza Hut, 24 Hour Fitness and a funeral casket and urn maker. Subscribe to read this story ad-free Get unlimited access to ad-free…

    US Set to Offer Iran Broad Financial Gains in Peace Deal

    (Bloomberg) — Iran is set to receive broad financial incentives as part of its agreement with the US, including the right to sell oil immediately, tap a $300 billion development…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Chase Sapphire Reserve for Business review: Premium perks for a high annual fee

    Chase Sapphire Reserve for Business review: Premium perks for a high annual fee

    More in store for the hardware crunch

    Pizza Hut bought by private equity firm that owns 24 Hour Fitness

    Pizza Hut bought by private equity firm that owns 24 Hour Fitness

    Brewers shortstop prospect Cooper Pratt called up ahead of series with Guardians

    Brewers shortstop prospect Cooper Pratt called up ahead of series with Guardians

    Save $100 Off a Pair of BowFlex Results Series SelectTech Dumbbells Ahead of Amazon Prime Day

    Save $100 Off a Pair of BowFlex Results Series SelectTech Dumbbells Ahead of Amazon Prime Day

    Best Abercrombie & Fitch Jeans to Shop Online: Low-Rise, Straight-Leg

    Best Abercrombie & Fitch Jeans to Shop Online: Low-Rise, Straight-Leg